{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T20:12:37Z","timestamp":1777147957794,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01HL145329-01"],"award-info":[{"award-number":["K01HL145329-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P40OD010965"],"award-info":[{"award-number":["P40OD010965"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T3OD01946"],"award-info":[{"award-number":["T3OD01946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ULTR1001420"],"award-info":[{"award-number":["ULTR1001420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008478","name":"Wake Forest School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011629","name":"Errett Fisher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114365","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T05:47:08Z","timestamp":1675748828000},"page":"114365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes"],"prefix":"10.1016","volume":"160","author":[{"given":"Giselle C.","family":"Mel\u00e9ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3600-9907","authenticated-orcid":false,"given":"Nazli","family":"Gharraee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin H.","family":"Goslen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masha","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordyn","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Widiapradja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott P.","family":"Levick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biopha.2023.114365_bib1","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of cardiology foundation\/american heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"39","key":"10.1016\/j.biopha.2023.114365_bib2","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114365_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114365_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114365_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.biopha.2023.114365_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011000","article-title":"Examining the relationship and prognostic implication of diabetic status and extracellular matrix expansion by cardiac magnetic resonance","volume":"13","author":"Khan","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"10","key":"10.1016\/j.biopha.2023.114365_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102659","article-title":"Replacement of lost substance P reduces fibrosis in the diabetic heart by preventing adverse fibroblast and macrophage phenotype changes","volume":"10","author":"Widiapradja","year":"2021","journal-title":"Cells"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2023.114365_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.regpep.2011.04.004","article-title":"Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P","volume":"169","author":"Ren","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biopha.2023.114365_bib10","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411001979","article-title":"Diabetic neuropathy and heart failure: role of neuropeptides","volume":"13","author":"Ejaz","year":"2011","journal-title":"Expert Rev. Mol. Med"},{"key":"10.1016\/j.biopha.2023.114365_bib11","doi-asserted-by":"crossref","first-page":"3425617","DOI":"10.1155\/2016\/3425617","article-title":"Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function","volume":"2016","author":"Roman-Pintos","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.114365_bib12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/oby.2007.199","article-title":"Characterization and heritability of obesity and associated risk factors in vervet monkeys","volume":"15","author":"Kavanagh","year":"2007","journal-title":"Obes. (Silver"},{"issue":"2","key":"10.1016\/j.biopha.2023.114365_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.114365_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiology.163.3.3575717","article-title":"Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging","volume":"163","author":"Sechtem","year":"1987","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.biopha.2023.114365_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.biopha.2023.114365_bib16","first-page":"63","article-title":"Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method","volume":"14","author":"Kellman","year":"2012","journal-title":"J. Cardiovasc Magn. Reson"},{"issue":"1","key":"10.1016\/j.biopha.2023.114365_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jmri.21119","article-title":"Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart","volume":"26","author":"Messroghli","year":"2007","journal-title":"J. Magn. Reson Imaging"},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114365_bib20","first-page":"64","article-title":"Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience","volume":"14","author":"Kellman","year":"2012","journal-title":"J. Cardiovasc Magn. Reson"},{"issue":"19","key":"10.1016\/j.biopha.2023.114365_bib21","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping","volume":"52","author":"Iles","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114365_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.biopha.2023.114365_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-018-5950-9","article-title":"MR extracellular volume mapping and non-contrast T1\u03c1 mapping allow early detection of myocardial fibrosis in diabetic monkeys","volume":"29","author":"Zhang","year":"2019","journal-title":"Eur. Radio."},{"issue":"5","key":"10.1016\/j.biopha.2023.114365_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcmg.2021.12.008","article-title":"Diabetes and myocardial fibrosis: a systematic review and meta-analysis","volume":"15","author":"Salvador","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.biopha.2023.114365_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ilar\/ilt049","article-title":"Systems biology of the vervet monkey","volume":"54","author":"Jasinska","year":"2013","journal-title":"ILAR J."},{"key":"10.1016\/j.biopha.2023.114365_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12872-015-0046-9","article-title":"Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging","volume":"15","author":"Qian","year":"2015","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.biopha.2023.114365_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J. Cardiovasc Magn. Reson"},{"issue":"8","key":"10.1016\/j.biopha.2023.114365_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jcmg.2018.06.006","article-title":"When left ventricular extracellular volume fraction changes after anthracyclines: is it due to a change in the numerator, denominator, or both?","volume":"11","author":"Hundley","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166044","article-title":"Diabetic fibrosis","volume":"1867","author":"Tuleta","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.114365_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113904","article-title":"Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities","volume":"176","author":"Tuleta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2023.114365_bib31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/ehjci\/jeu013","article-title":"Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy","volume":"15","author":"Jellis","year":"2014","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"key":"10.1016\/j.biopha.2023.114365_bib32","doi-asserted-by":"crossref","first-page":"6976153","DOI":"10.1155\/2020\/6976153","article-title":"Type 2 diabetes mellitus and chronic heart failure with midrange and preserved ejection fraction: a focus on serum biomarkers of fibrosis","volume":"2020","author":"Lebedev","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.biopha.2023.114365_bib33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.echo.2011.07.017","article-title":"Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?","volume":"24","author":"Ernande","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13475","article-title":"Assessment of subclinical diabetic cardiomyopathy by speckle-tracking imaging","volume":"51","author":"Minciun\u0103","year":"2021","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.114365_bib35","article-title":"Detecting regional fibrosis in hypertrophic cardiomyopathy: the utility of myocardial strain based on cardiac magnetic resonance","author":"She","year":"2022","journal-title":"Acad. Radiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114365_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCIMAGING.113.000842","article-title":"Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy","volume":"7","author":"Urbano-Moral","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"9","key":"10.1016\/j.biopha.2023.114365_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s10554-017-1115-1","article-title":"Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement","volume":"33","author":"Spartera","year":"2017","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"10.1016\/j.biopha.2023.114365_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/jphysiol.1983.sp014868","article-title":"On the mechanism of contraction and desensitization induced by substance P in the intestinal muscle of the guinea-pig","volume":"342","author":"Holzer","year":"1983","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114365_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-1716.1983.tb07304.x","article-title":"Substance P and capsaicin-induced contraction of human bronchi","volume":"119","author":"Lundberg","year":"1983","journal-title":"Acta Physiol. Scand."},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2004.05017.x","article-title":"Mechanisms of neurokinin A- and substance P-induced contractions in rat detrusor smooth muscle in vitro","volume":"94","author":"Quinn","year":"2004","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.biopha.2023.114365_bib41","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(16)30196-6","article-title":"Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis","volume":"4","author":"Natriuretic Peptides Studies","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114365_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13098-022-00837-6","article-title":"NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes","volume":"14","author":"Malachias","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040784","article-title":"Role of oxidative stress in diabetic cardiomyopathy","volume":"11","author":"De Geest","year":"2022","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.biopha.2023.114365_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10071084","article-title":"Substance-P inhibits cardiac microvascular endothelial dysfunction caused by high glucose-induced oxidative stress","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2023.114365_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118989","article-title":"The effect of miR-471-3p on macrophage polarization in the development of diabetic cardiomyopathy","volume":"268","author":"Liu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.114365_bib46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2014.00470","article-title":"Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?","volume":"5","author":"Kraakman","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.114365_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.metabol.2017.04.005","article-title":"Macrophage functions in lean and obese adipose tissue","volume":"72","author":"Thomas","year":"2017","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.biopha.2023.114365_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.biopha.2023.114365_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/imm.13002","article-title":"Properties and functions of adipose tissue macrophages in obesity","volume":"155","author":"Russo","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2023.114365_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.npep.2019.01.002","article-title":"Substance P-mediated cardiac mast cell activation: an in vitro study","volume":"74","author":"Levick","year":"2019","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.biopha.2023.114365_bib51","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvr244","article-title":"Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells","volume":"92","author":"Melendez","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.114365_bib52","first-page":"65","article-title":"Immunoregulatory effects of neuropeptides","volume":"37","author":"Rameshwar","year":"1992","journal-title":"Stimul. Inter. -2 Prod. Subst. p. J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114365_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071596","article-title":"Ion channels involved in substance P-mediated nociception and antinociception","volume":"20","author":"Chang","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114365_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-2000-7738","article-title":"Serum levels of substance P are decreased in patients with type 1 diabetes","volume":"108","author":"Kunt","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2023.114365_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1752-8062.2011.00318.x","article-title":"Expression of neuropeptide Y, substance P, and their receptors in the right atrium of diabetic patients","volume":"4","author":"Ejaz","year":"2011","journal-title":"Clin. Transl. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:55:17Z","timestamp":1776772517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":55,"alternative-id":["S0753332223001531"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114365","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114365"}}